Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database-Reference-Cited by-同舟云学术

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database

Published:2022-10-07 Issue:2 Volume:89 Page:865-873
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Zheng Yi¹^ORCID,Guo Xiaojing¹,Chen Chenxin¹^ORCID,Chi Lijie¹,Guo Zhijian¹,Liang Jizhou¹,Wei Lianhui¹,Chen Xiao¹,Ye Xiaofei¹,He Jia¹^ORCID

Affiliation:

1. Department of Health Statistics Naval Medical University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15535

Reference37 articles.

1. Treatment guidelines in psoriatic arthritis

2. Updated therapies for the management of Psoriatic Arthritis

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023;Frontiers in Pharmacology;2024-07-10

2. Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database;Expert Opinion on Drug Safety;2024-05-16

3. Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database;Scientific Reports;2024-01-12

4. IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment;International Immunopharmacology;2023-10

5. Adalimumab Therapeutic Drug Monitoring Improves Treatment Outcome in Patients with Psoriasis;Journal of Investigative Dermatology;2023-09